Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
Not provided
Not provided
Not provided
Not provided
This is a companion study to the "Pragmatic Randomized Trial of Proton vs Photon Therapy for Patients with non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial" (NCT02603341). The investigators will collect cardiovascular (CV) biomarkers and echocardiograms prior to, during, and for up to 1 year following radiation for a subset of patients enrolled on RadComp and to evaluate the impact of proton vs photon radiation therapy (RT) on CV function and structure.
The study population of the companion study will consist of newly enrolled RadComp trial participants. Patients on this ancillary will be consented prior to RadComp randomization to decrease the bias secondary to RT type and enhance internal validity. The study will define the early changes in biomarkers, imaging measures, and RT dose volume metrics and long-term (5-10 year) CV clinical outcomes using the RadComp parent study's infrastructure for clinical data collection and long-term follow-up. Blood samples, echocardiograms, and questionnaires are obtained at baseline (between end of chemotherapy and start of RT), immediately after the end of RT, and at 6 months and 12 months after the end of RT. An additional blood sample will be collected at 4 weeks after the start of RT. Clinical, demographic, and patient reported outcomes data are collected as part of the RadComp parent study. In addition to data collected by RadComp, we will collect a limited set of clinical data and two additional quality of life instruments for the companion study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ancillary Cohort | No Intervention: Subjects will be followed before, during and for up to 1 year after radiation with echocardiogram, blood draw, and symptoms and activity survey. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Proton vs Photon Radiation | Radiation | Assignment to proton vs photon by randomization on RadComp parent study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Left ventricular ejection fraction (LVEF) | Change in echocardiography derived LVEF from baseline | 14 months |
| Right Ventricular (RV) Fractional Area Change (FAC) | Change in echocardiography derived RV FAC from baseline | 14 months |
| Circulating N-terminal pro B-type natriuretic peptide (NTproBNP) | Change in NTproBNP levels from baseline | 14 months |
| Circulating Placental Growth Factor (PIGF) | Change in PIGF levels from baseline | 14 months |
| Circulating Growth Differentiation Factor-15 (GDF-15) | Change in GDF-15 levels from baseline | 14 months |
| Measure | Description | Time Frame |
|---|---|---|
| LV systolic strain | Change in 2D echocardiography derived LV global longitudinal strain and circumferential strain from baseline | 14 months |
| Echocardiography derived Ventricular Arterial Coupling Measurement |
| Measure | Description | Time Frame |
|---|---|---|
| 3D LVEF | Change in 3d echocardiography derived LVEF from baseline | 14 months |
| 3D LV systolic strain | Change in 3D echocardiography derived longitudinal and circumferential strain from baseline |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients eligible for and enrolling on the RadComp trial at participating RadComp sites will be approached for the companion cohort.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bonnie Ky, MD, MSCE | University of Pennsylvania | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35233 | United States | ||
| Northwestern Medicine |
Participants may opt in to allowing data and/or banked samples to be used for future research and shared with other researchers. A detailed plan for sharing IPD will be finalized at a later date, and may depend in part on how many participants elect this option. Additional supporting information may be shared, including the study protocol and informed consent form.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Plasma, Serum, and Buffy coat are collected.
Change from baseline in ventricular arterial coupling as defined by end systolic elastance divided by effective arterial elastance
| 14 months |
| Diastolic function (E/e') | Change in E/e' from baseline as measured by echocardiogram | 14 months |
| Circulating Troponin T(TnT) | Change in high-sensitivity TnT levels from baseline | 14 months |
| Circulating high-sensitivity C-Reactive Protein (hsCRP) | Change in hsCRP levels from baseline | 14 months |
| 14 months |
| LV Twist and Torsion | Change in 3D echocardiography derived measures of LV twist and torsion from baseline | 14 months |
| Patient Reported Outcomes (PRO) Common Terms and Criteria for Adverse Events (CTCAE) | Incidence and severity of PRO CTCAEs | 14 months |
| Incidence of major cardiovascular events (MCE) | Collected, defined, and adjudicated by the RadComp study team | 10 years |
| Warrenville |
| Illinois |
| 60555 |
| United States |
| Johns Hopkins | Baltimore | Maryland | 21287 | United States |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States |
| Abramson Cancer Center at University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States |
| University of Washington | Seattle | Washington | 98195 | United States |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D066126 | Cardiotoxicity |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D064420 | Drug-Related Side Effects and Adverse Reactions |
| D064419 | Chemically-Induced Disorders |
| D011832 | Radiation Injuries |
| D014947 | Wounds and Injuries |
Not provided
Not provided